Joachim Marr Selected Research

drospirenone

1/2015	Efficacy and safety of an oral contraceptive containing ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) in three indications in the People's Republic of China: a comparison with international studies.
5/2012	A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 μg/drospirenone 3 mg administered in a 21/7 regimen versus ethinylestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen.
4/2012	Long-term tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study.
4/2012	Contraceptive efficacy and tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study.
7/2011	Premenstrual dysphoric disorder symptom cluster improvement by cycle with the combined oral contraceptive ethinylestradiol 20 mcg plus drospirenone 3 mg administered in a 24/4 regimen.
5/2011	Ethinyl estradiol 20μg/drospirenone 3mg 24/4 oral contraceptive for the treatment of functional impairment in women with premenstrual dysphoric disorder.
4/2011	Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3mg administered in a 24/4 regimen: a pooled analysis.
1/2011	Cycle control and bleeding pattern of a 24/4 regimen of drospirenone 3 mg/ethinylestradiol 20 μg compared with a 21/7 regimen of desogestrel 150 μg/ethinylestradiol 20 μg: a pooled analysis.
11/2009	Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive.
8/2008	A combined oral contraceptive containing 3-mg drospirenone/ 20-microg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joachim Marr Research Topics

Disease

5	Hemorrhage 05/2012 - 09/2004
4	Acne Vulgaris 01/2015 - 04/2008
3	Premenstrual Dysphoric Disorder 01/2015 - 05/2011
2	Metrorrhagia (Spotting) 04/2012 - 04/2012
1	Pain (Aches) 06/2012
1	Endometriosis 06/2012
1	Syndrome (Syndromes) 07/2011

Drug/Important Bio-Agent (IBA)

12	drospirenone FDA LinkGeneric 01/2015 - 09/2004
8	Combined Oral ContraceptivesIBA 01/2015 - 09/2004
4	Oral ContraceptivesIBA 05/2012 - 04/2008
3	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 05/2011 - 08/2008
2	Contraceptive Agents (Contraceptives)IBA 01/2015 - 04/2012
2	TabletsIBA 04/2011 - 04/2008
2	Desogestrel FDA LinkGeneric 01/2011 - 11/2009
1	dienogest FDA Link 06/2012
1	Leuprolide (Lupron)FDA LinkGeneric 06/2012
1	Estrogens (Estrogen)FDA Link 04/2012
1	Progestins (Progestagens)IBA 04/2012
1	Estradiol (Delestrogen)FDA LinkGeneric 11/2009
1	Hormones (Hormone)IBA 09/2004

Therapy/Procedure

2	Contraception (Birth Control) 01/2015 - 08/2008